The latest news, approvals and clinical trials you need to know about this month
China has more than 80 running or pending clinical trials for potential COVID-19 treatments
The World Health Organization has forecast a 60% increase in global cancer cases if current trends continue
The number of countries in the African region to license the Ebola vaccine Ervebo
AstraZeneca has pledged $133m to expand its facility in Sydney, Australia
Mumps cases have hit a ten-year high in England
China has more than 80 running or pending clinical trials for potential COVID-19 treatments
The World Health Organization has forecast a 60% increase in global cancer cases if current trends continue
The number of countries in the African region to license the Ebola vaccine Ervebo
AstraZeneca has pledged $133m to expand its facility in Sydney, Australia
Mumps cases have hit a ten-year high in England
UK doctors are calling on Health Secretary Matt Hancock to investigate shortages of hormone replacement therapy and contraceptive drugs that have been affecting ‘thousands of women’ in the UK for at least a year.
Source: Pharmaphorum
In the UK, a new bill which aims to improve regulation for medical devices and ensure patient safety, as well as allow hospitals to develop personalised medicines has come into effect.
Source: Medscape
A study by the US National Institutes of Health (NIH) has demonstrated that Gilead’s antiviral drug, remdesivir, could prevent a type of coronavirus in monkeys.
Source: Pharmaceutical Technology
The e-commerce firm has applied for the trademark linked to the provision of pharmaceuticals, medical and veterinary preparations, online pharmacy retail, the delivery of prescription medications, and other services.
Source: The Pharmaceutical Journal
The US FDA has approved Pemfexy (pemetrexed for injection), a branded alternative to Alimta for the treatment of nonsquamous non-small cell lung cancer and malignant pleural mesothelioma.
Source: Business Wire
The European Commission has approved Novartis’ Beovu injection for the treatment of wet age-related macular degeneration.
Source: Novartis
The US FDA has approved Seqirus’ Audenz™ (Influenza A (H5N1) Monovalent Vaccine, Adjuvanted) to protect individuals six months of age and older against influenza A (H5N1).
Source: Seqirus
The US FDA has approved Voltaren Arthritis Pain (diclofenac sodium topical gel, 1% (NSAID)- arthritis pain reliever) as an over-the-counter (OTC) product for the temporary relief of arthritis pain in the hand, wrist, elbow, foot, ankle or knee in adults (18 years and older).
Source: GloaxoSmithKline